ATH 12.5% 0.4¢ alterity therapeutics limited

PBT2 in experimental cardiac amyloidosis,, page-10

  1. 2,810 Posts.
    lightbulb Created with Sketch. 975
    skint, I wrote Prana today and asked one. They should in fact explain how the "mitochondrion" hypothesis has changed almost everything. Think about how easy it is now to explain :
    - cognition improvements in AD and HD, sudden improvement of energy supply !
    - big biochemical changes seen in animal experiments ( Adlard et al 2014), there had to be a general factor which then improved metabolism and synthesis of needed proteins.
    - quick disappearance of amyloid in CSF when the cells have energy to pump amyloid away (Euro study), AD is an accumulation disease (no energy to pump amyloid away).
    - etc.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.4¢
Change
-0.001(12.5%)
Mkt cap ! $18.62M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $7.902K 2.037M

Buyers (Bids)

No. Vol. Price($)
40 53603756 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 126995306 20
View Market Depth
Last trade - 14.03pm 15/08/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.